Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Circulating Biomarkers in Migraine: New Opportunities for Precision Medicine
Patrizia Ferroni, Piero Barbanti, Antonella Spila, et al.
Current Medicinal Chemistry (2018) Vol. 26, Iss. 34, pp. 6191-6206
Closed Access | Times Cited: 31

Showing 1-25 of 31 citing articles:

Calcitonin Gene‐Related Peptide Modulators – The History and Renaissance of a New Migraine Drug Class
Richard Hargreaves, Jes Olesen
Headache The Journal of Head and Face Pain (2019) Vol. 59, Iss. 6, pp. 951-970
Closed Access | Times Cited: 116
Biomarkers of Migraine: An Integrated Evaluation of Preclinical and Clinical Findings
Chiara Demartini, Miriam Francavilla, Anna Maria Zanaboni, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 6, pp. 5334-5334
Open Access | Times Cited: 24
Salivary CGRP can monitor the different migraine phases: CGRP (in)dependent attacks
Alicia Alpuente, Victor J Gallardo, Laila Asskour, et al.
Cephalalgia (2021) Vol. 42, Iss. 3, pp. 186-196
Open Access | Times Cited: 46
CGRP and Migraine: What Have We Learned From Measuring CGRP in Migraine Patients So Far?
Katharina Kamm
Frontiers in Neurology (2022) Vol. 13
Open Access | Times Cited: 28
Plasma levels of CGRP and expression of specific microRNAs in blood cells of episodic and chronic migraine subjects: towards the identification of a panel of peripheral biomarkers of migraine?
Rosaria Greco, Roberto De Icco, Chiara Demartini, et al.
The Journal of Headache and Pain (2020) Vol. 21, Iss. 1
Open Access | Times Cited: 41
Migraine Treatment: Towards New Pharmacological Targets
Marcello Silvestro, Luigi Francesco Iannone, Ilaria Orologio, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 15, pp. 12268-12268
Open Access | Times Cited: 16
Hsa-miR-34a-5p and hsa-miR-375 as Biomarkers for Monitoring the Effects of Drug Treatment for Migraine Pain in Children and Adolescents: A Pilot Study
Luca Gallelli, Erika Cione, Fancesco Peltrone, et al.
Journal of Clinical Medicine (2019) Vol. 8, Iss. 7, pp. 928-928
Open Access | Times Cited: 39
Current Evidence on Potential Uses of MicroRNA Biomarkers for Migraine: From Diagnosis to Treatment
Parisa Gazerani
Molecular Diagnosis & Therapy (2019) Vol. 23, Iss. 6, pp. 681-694
Closed Access | Times Cited: 36
Dynamic fluctuations of salivary CGRP levels during migraine attacks: association with clinical variables and phenotypic characterization
Alicia Alpuente, Victor J Gallardo, Laila Asskour, et al.
The Journal of Headache and Pain (2024) Vol. 25, Iss. 1
Open Access | Times Cited: 4
CGRP Inhibitors and Oxidative Stress Biomarkers in Resistant Migraine: A Real-Life Study with Erenumab, Fremanezumab, and Galcanezumab
Ciro De Luca, Filippo Baldacci, Sonia Mazzucchi, et al.
Journal of Clinical Medicine (2021) Vol. 10, Iss. 19, pp. 4586-4586
Open Access | Times Cited: 18
The role of the immune system and the biomarker CD3 + CD4 + CD45RA−CD62L− in the pathophysiology of migraine
Zbyšek Pavelek, Ondřej Souček, Jan Krejsek, et al.
Scientific Reports (2020) Vol. 10, Iss. 1
Open Access | Times Cited: 16
The role of a potential biomarker in patients with migraine: review and new insights
Karen S. Ferreira, Harjot Dhillon, Ana Míriam Velly
Expert Review of Neurotherapeutics (2021) Vol. 21, Iss. 7, pp. 817-831
Closed Access | Times Cited: 15
Migraine Treatment: Towards New Pharmacological Targets
Marcello Silvestro, Luigi Francesco Iannone, Ilaria Orologio, et al.
(2023)
Open Access | Times Cited: 5
Inflammation in migraine…or not…: A critical evaluation of the evidence
Andrew Charles, Sinifunanya E. Nwaobi, Peter J. Goadsby
Headache The Journal of Head and Face Pain (2021) Vol. 61, Iss. 10, pp. 1575-1578
Closed Access | Times Cited: 11
Evaluation of the relationship between migraine and psoriasis: a case-control study
Mohamad Sarkhani, Majid Rostami Mogaddam, Ghasem Fattahzadeh‐Ardalani, et al.
Anais Brasileiros de Dermatologia (2023) Vol. 98, Iss. 3, pp. 316-323
Open Access | Times Cited: 4
The Association Between Periodontal Disease and Chronic Migraine: A Systematic Review
Marwan Mansoor Ali Mohammed, Danah Almayeef, d. Batal Rida Abbas, et al.
International Dental Journal (2023) Vol. 73, Iss. 4, pp. 481-488
Open Access | Times Cited: 4
Are we closer to achieving precision medicine for migraine treatment? A narrative review
Keiko Ihara, Francesco Casillo, Ahmed Dahshan, et al.
Cephalalgia (2024) Vol. 44, Iss. 9
Closed Access | Times Cited: 1
Deep and unbiased proteomics, pathway enrichment analysis, and protein–protein interaction of biomarker signatures in migraine
Yohannes W. Woldeamanuel, Bharati M. Sanjanwala, Robert P. Cowan
Therapeutic Advances in Chronic Disease (2024) Vol. 15
Open Access | Times Cited: 1
Metabolic profile changes in serum of migraine patients detected using 1H-NMR spectroscopy
Aster V. E. Harder, Lisanne S. Vijfhuizen, Peter Henneman, et al.
The Journal of Headache and Pain (2021) Vol. 22, Iss. 1
Open Access | Times Cited: 10
Urinary Proteomics Reveals Promising Biomarkers in Menstrually Related and Post-Menopause Migraine
Elisa Bellei, Stefania Bergamini, Cecilia Rustichelli, et al.
Journal of Clinical Medicine (2021) Vol. 10, Iss. 9, pp. 1854-1854
Open Access | Times Cited: 8
Serological Biomarkers of Chronic Migraine
Soomi Cho, Min Kyung Chu
Current Pain and Headache Reports (2023) Vol. 27, Iss. 10, pp. 531-542
Closed Access | Times Cited: 3
Blood Biomarkers for Assessing Headaches in Healthcare Workers after Wearing Biological Personal Protective Equipment in a COVID-19 Field Hospital
Francisco Martín‐Rodríguez, Raúl López‐Izquierdo, Raquel M. Portillo Rubiales, et al.
Journal of Personalized Medicine (2021) Vol. 11, Iss. 1, pp. 27-27
Open Access | Times Cited: 5
Investigation of the plasma copeptin level in cases with childhood migraine
Halil Kazanasmaz, Mustafa Çalık, Hüseyin Gümüş, et al.
Human & Experimental Toxicology (2020) Vol. 40, Iss. 6, pp. 952-959
Closed Access | Times Cited: 4
Low pulse pressure and high serum complement C1q are risk factors for hemodialysis headache: A case–control study
Quan Gan, Lily Zhang, Yuting Fang, et al.
Headache The Journal of Head and Face Pain (2024) Vol. 64, Iss. 3, pp. 285-298
Closed Access
Salivary CGRP as diagnostic and migraine attack phase monitor biomarker: CGRP (in)dependent attacks
Alicia Alpuente, Victor J Gallardo, Laila Asskour, et al.
medRxiv (Cold Spring Harbor Laboratory) (2020)
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top